| Gene symbol | ERVE-1 | Synonyms | ERVE1, HERV-E1, HERVE1 | Type of gene | other |
| Chromosome | 17 | Map location | 17q11.2 | dbXrefs | |
| Description | endogenous retrovirus group E member 1 | ||||
| GTO ID | GTC1820 |
| Trial ID | NCT03354390 |
| Disease | Kidney Cancer |
| Altered gene | HERV-E1 |
| Therapeutic/Target gene | Target gene |
| Therapy | TCR-T cell |
| Treatment | HERV-E TCR-T cells |
| HLA | HLA-A*11:01 |
| Phase | Phase1 |
| Recruitment status | Recruiting |
| Title | A Phase I Study of HERV-E TCR Transduced Autologous T Cells in Patients With Metastatic Clear Cell Renal Cell Carcinoma |
| Year | 2017 |
| Country | United States |
| Company sponsor | National Heart, Lung, and Blood Institute (NHLBI) |
| Other ID(s) | 180012|18-H-0012 |
| Cohort 1 | |||||||||
|
|||||||||